Global demand for the tissue engineering market was approx USD 9.88 billion in 2019 and is expected revenue of around USD 25.68 billion by end of 2026
The report covers forecasts and analyses for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecasts from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the tissue engineering market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the tissue engineering market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the tissue engineering market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new indication launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the tissue engineering market on global and regional basis.
The study provides a crucial view on the tissue engineering by segmenting the market based on application and region. All the segments of tissue engineering market have been analyzed based on present and future trends and the market is estimated from 2016 to 2026.
The global demand for tissue engineering market is driven by growing adoption of tissue engineering in regenerative medicine industry, rise in healthcare expenditure, and increasing funding for research and development. However, lack of awareness and high cost may act as restraining factors for the market growth in the coming years. Increasing collaboration and technological advancements are projected to bring new growth avenues for market players during the forecast timeframe.
The tissue engineering market has been divided into application and region. Based on application, global tissue engineering market is segmented into gynecology, cell banking & cord blood, dental, urology, integumentary & skin, cardiology, neurology, musculoskeletal, orthopedics, & spine, and others. Market was dominated by musculoskeletal, orthopedics, & spine segment in 2019 and is projected to retain its dominance over the forecast timeframe. This is because of high number of spine and orthopedic surgeries.
North America held largest revenue share of the global tissue engineering market in 2018. This large share is attributed to high prevalence of lifestyle related disorders, government funding, and presence of state-of-the-art treatment facilities in this region. Europe was second leading regional market in terms of revenue. Availability of developed infrastructure, increasing geriatric population, and growing awareness are major factors that support market growth in this region. Asia Pacific region is projected to be rapidly growing regional market for tissue engineering. Increasing geriatric population base, improvement of healthcare infrastructure, increasing disposable income and healthcare spending, growing awareness are major factors attributing to the swift growth in this region. Moderate growth is projected in Latin America region over the forecast period. Middle East and Africa will witness sluggish growth in the coming years.
Report Attributes | Report Details |
---|---|
Report Name | Tissue Engineering Market Research Survey Report |
Market Size in 2019 | USD 9.88 Billion |
Market Forecast by 2026 | USD 25.68 Billion |
Compound Annual Growth Rate | CAGR of 14.8% |
Number of Pages | 126 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Zimmer Biomet Holdings Inc, Medtronic plc, Allergan plc, ell Inc, Athersys Inc, Tissue Regenix Group plc, Organogenesis Holdings Inc, Stryker Corporation, Integra LifeSciences Corporation, RTI Surgical Inc, Baxter International Inc, ReproCell Inc, and Integra Life Sciences Corporation among others |
Segments Covered | By Application, By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2019 |
Historical Year | 2016 - 2018 |
Forecast Year | 2020 - 2026 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Major players in tissue engineering market are Zimmer Biomet Holdings, Inc, Medtronic plc, Allergan plc, ell, Inc., Athersys, Inc, Tissue Regenix Group plc, Organogenesis Holdings Inc, Stryker Corporation, Integra LifeSciences Corporation, RTI Surgical, Inc., Baxter International, Inc., ReproCell, Inc., and Integra LifeSciences Corporation among others.
Global Tissue engineering Market: Application
FrequentlyAsked Questions
Influencing segment growing in the Tissue Engineering Market are By Application (Gynecology, Cell Banking & Cord Blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, And Others)
The CAGR value of the Tissue Engineering market will be 14.8% between 2020 and 2026
The Market Size value of the Tissue Engineering market by 2026 will be USD 25.68 billion
Major players / leading companies in the tissue engineering market are Zimmer Biomet Holdings, Inc, Medtronic plc, Allergan plc, ell, Inc., Athersys, Inc, Tissue Regenix Group plc, Organogenesis Holdings Inc, Stryker Corporation, Integra LifeSciences Corporation, RTI Surgical, Inc., Baxter International, Inc., ReproCell, Inc., and Integra LifeSciences Corporation among others
The global demand for tissue engineering market is driven by growing adoption of tissue engineering in regenerative medicine industry, rise in healthcare expenditure, and increasing funding for research and development. However, lack of awareness and high cost may act as restraining factors for the market growth in the coming years. Increasing collaboration and technological advancements are projected to bring new growth avenues for market players during the forecast timeframe.
North America contribute notably towards the global Tissue Engineering Market Revenue
North America held largest revenue share of the global tissue engineering market in 2018. This large share is attributed to high prevalence of lifestyle related disorders, government funding, and presence of state-of-the-art treatment facilities in this region.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed